Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,447,931
  • Shares Outstanding, K 156,453
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 73,400 K
  • EBIT $ 110 M
  • EBITDA $ 220 M
  • 60-Month Beta 1.48
  • Price/Sales 8.45
  • Price/Cash Flow 26.94
  • Price/Book 5.12

Options Overview Details

View History
  • Implied Volatility 44.86% (-2.26%)
  • Historical Volatility 37.29%
  • IV Percentile 34%
  • IV Rank 30.78%
  • IV High 71.44% on 04/07/25
  • IV Low 33.04% on 02/21/25
  • Expected Move (DTE 13) 4.29 (6.43%)
  • Put/Call Vol Ratio 0.81
  • Today's Volume 165
  • Volume Avg (30-Day) 2,987
  • Put/Call OI Ratio 1.78
  • Today's Open Interest 22,878
  • Open Int (30-Day) 24,183
  • Expected Range 62.49 to 71.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.48
  • Number of Estimates 6
  • High Estimate 0.51
  • Low Estimate 0.45
  • Prior Year 0.50
  • Growth Rate Est. (year over year) -4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.69 +8.24%
on 02/04/26
72.16 -7.46%
on 01/22/26
+1.50 (+2.30%)
since 01/06/26
3-Month
56.53 +18.13%
on 11/07/25
72.16 -7.46%
on 01/22/26
+8.60 (+14.78%)
since 11/06/25
52-Week
46.01 +45.14%
on 04/21/25
75.69 -11.77%
on 02/07/25
-8.23 (-10.97%)
since 02/06/25

Most Recent Stories

More News
TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets

TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets

TECH : 66.78 (+1.40%)
Techne: Fiscal Q2 Earnings Snapshot

Techne: Fiscal Q2 Earnings Snapshot

TECH : 66.78 (+1.40%)
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales

Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales

TECH : 66.78 (+1.40%)
Bio-Techne Declares Dividend

MINNEAPOLIS , Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December...

TECH : 66.78 (+1.40%)
Bio-Techne Releases Second Quarter Fiscal 2026 Results

MINNEAPOLIS , Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2025.

TECH : 66.78 (+1.40%)
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect

Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect

TECH : 66.78 (+1.40%)
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

MINNEAPOLIS , Feb. 2, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the launch of Cultrexâ„¢...

TECH : 66.78 (+1.40%)
3 Unpopular Stocks That Concern Us

3 Unpopular Stocks That Concern Us

TECH : 66.78 (+1.40%)
PKG : 238.86 (+3.00%)
BMY : 61.99 (+4.15%)
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

MINNEAPOLIS , Jan. 28, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of Simple...

TECH : 66.78 (+1.40%)
3 Cash-Producing Stocks That Fall Short

3 Cash-Producing Stocks That Fall Short

TECH : 66.78 (+1.40%)
TXG : 18.61 (+5.14%)
DHI : 156.27 (-1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 69.39
2nd Resistance Point 68.50
1st Resistance Point 67.64
Last Price 66.78
1st Support Level 65.88
2nd Support Level 64.99
3rd Support Level 64.13

See More

52-Week High 75.69
Last Price 66.78
Fibonacci 61.8% 64.35
Fibonacci 50% 60.85
Fibonacci 38.2% 57.35
52-Week Low 46.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar